SRAX Inc. (NASDAQ: SRAX) Innovative Initiatives Lead to

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
224
SRAX Inc. (NASDAQ: SRAX) Innovative Initiatives Lead to Sales Rebound Despite Bleak Economic Environment

- SRAX held its FY2019 and Q1 FY2020 results conference call on May 4, 2020
- The company reported year-over-year revenue growth of 3% for FY2019
- SRAX Q2 revenues staged recovery despite COVID-19 woes due to innovative Stock for Ads program
- The company also saw increased traffic on, demand for BIGtoken platform as well as rebranded Sequire investor relations tool, both of which have witnessed strong uptick in sales in recent weeks

SRAX Inc. (NASDAQ: SRAX), a digital marketing company focused on providing consumer data-management services, recently held its FY2019 and Q12020 results conference call (http://nnw.fm/JRe52). Despite unprecedented business challenges presented worldwide by COVID-19, the company was able to report strong results due to its product suite being ideally positioned to capitalize on the global shift to a fully digital economy in early 2020.

SRAX’s fiscal 2019 revenues of $3.6 million showed a 3% year-to-year increase while Q1 2020 sales fell to $350 thousand relative to the $592 thousand recorded in 2019, the latter decline largely a result of customers opting to defer their media spend to the second quarter. While first quarter revenues tend to mark the seasonal low for the company, SRAX was able to launch new initiatives, namely its pioneering Stock for Ads program and BIGtoken Lighting Insights platform, both of which have contributed to a significant sales rebound in the second quarter.

“The first quarter of the year tends to be seasonally adjusted, the lowest time of the year for the company […] most of the revenue from that time frame comes in the March area” SRAX Chairman and CEO Christopher Miglino stated in a news release. “Many of the companies that paused media in March when the pandemic was in full swing are beginning to launch those programs back up in May.”

A key driver for the company’s recent surge in marketing revenues has been its innovative Stock for Ads program, which has enabled customers to launch new media campaigns while paying with stock, thereby permitting companies to conserve cash. SRAX has sought to expand the scope of its program by tabling agreements with 31 banks and brokers, including the likes of B. Riley Financial Inc., who in turn have sought to promote and cross-sell SRAX’s marketing capabilities and Stocks for Ads program to their underlying client bases. Thus far this year, publicly-listed US companies have raised capital by selling stock at over twice the pace at which they did in 2019 (http://nnw.fm/7KTdD), a clear illustration of the popularity and potential of equity-based financing options.

SRAX also reported a strong uptick in the use of its BIGtoken Lightning Insights platform (http://nnw.fm/7OaeU). The platform allows SRAX’s customers to harness the collective insights of BIGtoken’s 16.7 million registered users, providing brands with a prompt and deeper understanding as to its consumer mindset-related queries. CEO Christopher Miglino revealed that SRAX “saw our first substantial revenue for our BIGtoken product in Q4 of 2019,” with the company recognizing approximately $450 thousand in sales at a 50% margin.

SRAX highlighted the unique capabilities of their proprietary BIGtoken platform by referencing a recent campaign which the company carried out for Kraft. Through the use of SRAX’s BIGtoken tool, Kraft was able to launch an extremely targeted marketing campaign, resulting in a 6.6% return on ad spend (http://nnw.fm/lWT6q). SRAX’s management highlighted the potential of its proprietary marketing solution by contrasting the Kraft campaign to those recently carried out by Walmart and Evite, which delivered flat and negative returns, respectively. Moreover, the company also revealed that the positive returns from the marketing campaign had prompted the client to subsequently follow through with a substantial purchase.

Moreover, SRAX seized the opportunity to elaborate upon the rebranding of its investor intelligence platform, SRAX IR to Sequire. The investor relations platform, which enables companies to identify, manage and communicate with their investor base in a unique and seamless manner, announced that it had gained 59 corporate subscribes to date, a remarkable 62% increase relative to the quarter ending September 30, 2019. The company further announced its addition of functionalities to the platform, including the ability for companies to take advantage of marketing services, exploiting the synergies existent within its various product offerings in a bid to maximize potential revenues.

In addition to its ongoing business lines, SRAX management also touched upon its 2018 sale of SRAXmd, which has since been rebranded as TI Health. SRAX has retained a 31% stake in the business with CEO Christopher Miglino attributing a carrying value to the asset of approximately $12 million following several quarters of 8% annualized growth. Remarkably, the value of the stake would be equivalent to nearly 50% of SRAX’s current market cap.

Finally, the company also revealed that it had been extremely diligent in safeguarding its business in response to the onset of the global pandemic in the first quarter. As of March, SRAX had implemented cost savings measures resulting in the elimination of over $3 million in annualized expenses while simultaneously identifying a further $600 thousand in cost cuts to be implemented in the coming months. Separately, the company entered into a $5 million debt financing agreement with B. Riley Financial Inc. to further safeguard its balance sheet liquidity while also announcing the procurement of a $1.1 million PPP loan at the beginning of May.

For more information, visit the company’s website at www.SRAX.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

SRAX Inc. (SRAX) Stock Research Links

SRAX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Chemical Industry and EPA: A Broken System?

Updated Category News Views 0

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 0

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 0

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 0

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 0

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 0

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 3

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 0

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Verizon Communications Options Activity Highlights and Insights

Updated Category News Views 136

Verizon Communications Options Activity Insights Investors have been keeping a close eye on Verizon Communications as recent activity indicates an intriguing trend. Notably, large investors have been exhibiting a bearish attitude towards Verizon Communications. Analyzing the Options Activity Upon reviewing the options history for Verizon Communications (VZ), we identified...

Continue Reading
Economic Insights: Dollar, Treasury ETFs, and Oil Market Trends

Updated Category News Views 478

The Dynamics of Today’s Economic Landscape The world of economics is continuously evolving, and this week has proven to be particularly eventful. From debates about the U.S. dollar's role in global finance to fluctuations in oil prices, there are many essential updates to consider. Let’s explore these pivotal developments that have caught the attention of investors...

Continue Reading
Forecasted Growth of US Unmanned Surface Vehicles Market

Updated Category News Views 105

Overview of the US Unmanned Surface Vehicles Market The US unmanned surface vehicles (USVs) market is on a remarkable trajectory, expected to reach $362.4 million by 2028. Estimated at $247.2 million in 2024, this signifies a robust compound annual growth rate (CAGR) of 9.5% throughout the forecast period. Enhancements in technology and an increasing reliance on USVs for...

Continue Reading
Understanding Balanced Commercial Property Trust Limited Disclosures

Updated Category News Views 173

Public Opening Position Disclosure Overview In the world of finance and investing, transparency is key. For companies like Balanced Commercial Property Trust Limited, adhering to disclosure regulations is vital. This article delves into the details surrounding public opening position disclosures and the responsibilities of significant shareholders as outlined under Rule...

Continue Reading
BCA Research Upgrades Auto Sector Boosted by Tesla Revival

Updated Category News Views 221

BCA Research Upgrades Auto Sector Amid Tesla’s Recovery BCA Research has recently elevated its perspective on the Auto & Components sector to an overweight position. This change is attributed to a notable resurgence led by Tesla's (NASDAQ: TSLA) surprising performance in the third quarter. Tesla's Dominance in the Auto Market Tesla continues to hold a substantial...

Continue Reading